Home > Products > Specialty & Industrial Chemicals > Specialty Chemicals > PIPERIDIN-1-YL(QUINOXALIN-6-YL)METHANONE
PIPERIDIN-1-YL(QUINOXALIN-6-YL)METHANONE structure, CAS 154235-83-3

PIPERIDIN-1-YL(QUINOXALIN-6-YL)METHANONE

CAS Number154235-83-3

Synonymspiperidin-1-yl(quinoxalin-6-yl)methanone; 1-Piperidinyl(6-quinoxalinyl)methanone; 1-(quinoxalin-6-ylcarbonyl)piperidine; Ampalex; BDP-12

Molecular FormulaC14H15N3O

Molecular Weight241.29

Purity≥98 (HPLC)%

Density1.2±0.1 g/cm3

Boiling Point433.1±25.0 °C at 760 mmHg

Melting Point88-90ºC

Flash Point

Appearancepowder

EINECS0

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-0163524 Purity: ≥98 (HPLC)%
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 154235-83-3 ] Purity: ≥98 (HPLC)% SDS Specification MoL

Chemical & Physical Properties
CAS Number154235-83-3
Catalog No.2A-0163524
Chinese Name安帕来斯
Synonymspiperidin-1-yl(quinoxalin-6-yl)methanone; 1-Piperidinyl(6-quinoxalinyl)methanone; 1-(quinoxalin-6-ylcarbonyl)piperidine; Ampalex; BDP-12
Molecular FormulaC14H15N3O
Molecular Weight241.29
Purity≥98 (HPLC)
Density1.2±0.1 g/cm3
Boiling Point433.1±25.0 °C at 760 mmHg
Melting Point88-90ºC
Appearancepowder
Storage Condition2~8℃
ApplicationAmpalex (Ampakine CX516; CX516; BDP 12) is a positive allosteric modulator of AMPA receptors and can act on Alzheimer's disease, schizophrenia, etc.
EINECS0
HTC2933990090
UN(IATA)0
PubChem ID329825710
MDL NumberMFCD00943201
SMILESO=C(C1=CC2=NC=CN=C2C=C1)N3CCCCC3
InChI1S/C14H15N3O/c18-14(17-8-2-1-3-9-17)11-4-5-12-13(10-11)16-7-6-15-12/h4-7,10H,1-3,8-9H2
InChI KeyANDGGVOPIJEHOF-UHFFFAOYSA-N
NACRES CodeNA.77
UNSPSC12352200
MSDSmsds/163524_1_154235_83_3.pdf
Use ofAmpalex (Ampakine CX516; CX516; BDP 12) is an ampakine and nootropic that acts as an AMPA receptor positive allosteric modulator as a treatment for Alzheimer's disease, schizophrenia and mild cognitive impairment (MCI). IC50 value: Target: AMPA receptorAmpalex ameliorates functional deficits in AMPA receptors in a hippocampal slice model of protein accumulation. Researches suggest that AMPA receptors may be potential pharmaceutical targets for the treatment of neurodegenerative diseases, and highlights AMPAkines, in particular, as possible therapeutic agents. Properties Name Piperidin-1-yl(quinoxalin-6-yl)methanone Synonym More Synonyms Ampalex Biological Activity Description Ampalex (Ampakine CX516; CX516; BDP 12) is an ampakine and nootropic that acts as an AMPA receptor positive allosteric modulator as a treatment for Alzheimer's disease, schizophrenia and mild cognitive impairment (MCI). IC50 value: Target: AMPA receptorAmpalex ameliorates functional deficits in AMPA receptors in a hippocampal slice model of protein accumulation. Researches suggest that AMPA receptors may be potential pharmaceutical targets for the treatment of neurodegenerative diseases, and highlights AMPAkines, in particular, as possible therapeutic agents. Related Catalog Signaling Pathways >> Membrane Transporter/Ion Channel >> iGluR Signaling Pathways >> Neuronal Signaling >> iGluR Research Areas >> Neurological Disease References [1]. Broberg BV, Glenth?j BY, Dias R, et al. Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia--sub-chronic and early postnatal PCP treatment in attentional set-shifting. Psychopharmacology (Berl). 2009 [2]. Kanju PM, Parameshwaran K, Sims C, et al. Ampakine CX516 ameliorates functional deficits in AMPA receptors in a hippocampal slice model of protein accumulation. Exp Neurol. 2008 Nov;214(1):55-61. [3]. Goff DC, Lamberti JS, Leon AC, et al. A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia. Neuropsychopharmacology. 2008 Feb;33(3):465-72. [4]. O'Neill MJ, Witkin JM. AMPA receptor potentiators: application for depression and Parkinson's disease. Curr Drug Targets. 2007 May;8(5):603-20. [5]. Johnson SA, Simmon VF. Randomized, double-blind, placebo-controlled international clinical trial of the Ampakine CX516 in elderly participants with mild cognitive impairment: a progress report. J Mol Neurosci. 2002 Aug-Oct;19(1-2):197-200. Chemical & Physical Properties Molecular Formula C14H15N3O Exact Mass 241.121506 PSA 46.09000 Index of Refraction 1.640 InChIKey ANDGGVOPIJEHOF-UHFFFAOYSA-N Storage condition 2~8℃ Safety Information Signal Word Warning Hazard Statements H302 Hazard Codes Xi RIDADR NONH for all modes of transport RTECS TM2785170 HS Code 2933990090
Tax Rebate13.0%
SupervisionNone. MFN tariff: 6.5%. Ordinary tariff: 20.0%
Transport InfoProduct name: Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA